All Stories

  1. P450 in Liver Pathology Diagnostic
  2. Key Points in HIV Infection
  3. An Approach on HIV Infection
  4. HIV Infection a Social and a Healthcare Problem
  5. OPPORTUNISTIC PATHOGENS IN PATIENTS WITH URINARY TRACT INFECTION
  6. Opportunistic Pathogens in Patients with Urinary Tract Infection
  7. Opportunistic Pathogens in Patients with Urinary Tract Infection
  8. Laboratory Methods in the Screening of Viral C Hepatitis
  9. Disinfectants
  10. Microbial Contamination in Water Systems
  11. Editorial Comment
  12. Assessment of airborne endotoxin in sandstorm dust and indoor environments using a novel passive sampling device in Al Zulfi city, Saudi Arabia – Establishing threshold exposure levels
  13. Virulence profiles of some Pseudomonas aeruginosa clinical isolates and their association with the suppression of Candida growth in polymicrobial infections
  14. Potential Drugs for Treating COVID-19 Infection
  15. Significant help
  16. Study of contact plates recovery from pharmaceutical cleanroom surfaces across three-time ranges
  17. Robust infection prevention
  18. Review of the efficacy of HEPA filtered air to control coronavirus risks in cleanrooms
  19. Antimicrobial Activity of Silver-Treated Bacteria against other Multi-Drug Resistant Pathogens in Their Environment
  20. Assessing Gram-stain error rates within the pharmaceutical microbiology laboratory
  21. COVID-19 and dental practice
  22. Utilities Design and Testing
  23. Use of Hazard Analysis Critical Control Point (HACCP) methodology for biocontamination control: Assessing microbial risks and to determining environmental monitoring locations
  24. A novel mechanism of action of ketoconazole: inhibition of the NorA efflux pump system and biofilm formation in multidrug-resistant Staphylococcus aureus
  25. Particle Counting
  26. Cleanroom Microbiota
  27. Biocontamination Deviation Management
  28. Assessment of Pharmaceutical Water Systems
  29. Bioburden and Endotoxin Control in Pharmaceutical Processing
  30. Biocontamination Control Strategy
  31. Cleanrooms and Environmental Monitoring
  32. Data Handling and Trend Analysis
  33. Designing and Implementing an Environmental Monitoring Program
  34. GMP, Regulations and Standards
  35. Introduction to Biocontamination and Biocontamination Control
  36. Rapid and Alterative Microbiological Methods
  37. Risk Assessment and Investigation for Environmental Monitoring
  38. Selection and Application of Culture Media
  39. Sources of Microbial Contamination and Risk Profiling
  40. Special Types of Environmental Monitoring
  41. The Human Factor and Biocontamination Control
  42. Viable Environmental Monitoring Methods
  43. Disinfectants and Biocides
  44. A review on biocide reduced susceptibility due to plasmid-borne antiseptic-resistant genes-special notes on pharmaceutical environmental isolates
  45. Distribution of biocide resistant genes and biocides susceptibility in multidrug-resistant Klebsiella pneumoniae , Pseudomonas aeruginosa and Acinetobacter baumannii — A first report from the Kingdom of Saudi Arabia
  46. Microbiological Test Data—Assuring Data Integrity
  47. Cleaning and disinfection of dental practice surfaces
  48. A study of airborne fungal allergens in sandstorm dust in Al-Zulfi, Central region of Saudi Arabia
  49. Chapter 7 Clean room design principles
  50. Evaluation of quaternary ammonium compound disinfectants against mycobacteria in dental practices
  51. A review of melanized (black) fungal contamination in pharmaceutical products-incidence, drug recall and control measures
  52. Bacteriophages offer an Antimicrobial Solution
  53. Manufacturing and validation
  54. Microbial identification
  55. Biological indicators
  56. Microbiological data
  57. Bioburden determination
  58. Introduction
  59. Auditing the microbiology laboratory
  60. Introduction to pharmaceutical microbiology
  61. Microbiological challenges to the pharmaceuticals and healthcare
  62. Endotoxin and pyrogen testing
  63. Microbiological culture media
  64. Sterilization and sterility assurance
  65. Microbiology and pharmaceuticals
  66. Cleanrooms and environmental monitoring
  67. Laboratory management and design
  68. Antibiotics and preservatives
  69. GMP and regulations
  70. Rapid microbiological methods
  71. Risk assessment and microbiology
  72. Specified and objectionable microorganisms
  73. Cleaning and disinfection
  74. Microbiology laboratory techniques
  75. Assessment of pharmaceutical water systems
  76. Determination of Minimum inhibitory concentrations of Common Biocides to Multidrug-Resistant Gram-negative bacteria
  77. Pharmaceutical Microbiology
  78. Advances in Rapid Pathogen Detection
  79. Characterizing the Microbiota of a Pharmaceutical Water System-A Metadata Study
  80. Evaluating biocides to kill fungi
  81. Teixobactin: A New Class of Antibiotic
  82. In vitro fungicidal activity of biocides against pharmaceutical environmental fungal isolates
  83. Rapid microbiological methods for cleanroom environments
  84. Interview: Pharmaceutical microbiology
  85. Trichoderma
  86. FUNGI | Classification of the Peronosporomycetes
  87. Laboratory Design
  88. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Enterobacteriaceae, Coliforms, and Escherichia Coli
  89. BIOCHEMICAL AND MODERN IDENTIFICATION TECHNIQUES | Food-Poisoning Microorganisms
  90. Novel Methods to Address Antimicrobial Resistance
  91. The Possible Origins of Tuberculosis in South America
  92. Comparative Evaluation of Traditional Susceptibility Testing for MRSA with the PCR Approach
  93. Comparison of Different Fungal Agar for the Environmental Monitoring of Pharmaceutical-Grade Cleanrooms
  94. Sterility, sterilisation and sterility assurance for pharmaceuticals
  95. Preface
  96. Introduction
  97. Sterility, sterilisation and microorganisms
  98. Pyrogenicity and bacterial endotoxin
  99. Gamma radiation
  100. Electron beam processing
  101. Dry heat sterilisation
  102. Steam sterilisation
  103. Gaseous sterilisation
  104. Hydrogen peroxide vapour sterilisation
  105. Sterilisation by filtration
  106. Other methods of sterilisation
  107. Media simulation trials
  108. Aseptic processing and filling
  109. Depyrogenation and endotoxin
  110. Biological indicators
  111. Regulatory requirements and Good Manufacturing Practices (GMP)
  112. Investigating sterility test failures
  113. The Sterility Test
  114. Cleanrooms, isolators and cleanroom technology
  115. Cleaning and disinfection of sterile processing facilities
  116. Auditing sterilisation processes and facilities
  117. Pharaohs and Mummies: Diseases of Ancient Egypt and Modern Approaches
  118. Global Strategies for Elimination of Leprosy: A Review of Current Progress
  119. Could the ‘Black Death’ Become a Re-Emerging Infectious Disease?
  120. Study of psychrophilic and psychrotolerant micro-organisms isolated in cold rooms used for pharmaceutical processing
  121. Application of Quality Risk Management To Set Viable Environmental Monitoring Frequencies in Biotechnology Processing and Support Areas
  122. In vitro Antifungal Efficacy of Biguanides and Quaternary Ammonium Compounds against Cleanroom Fungal Isolates
  123. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  124. Some considerations for the implementation of disposable technology and single-use systems in biopharmaceuticals
  125. A Review of Cleanroom Microflora: Types, Trends, and Patterns